{"trigger": ["<extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> Promotes Tumor Growth and Survival through Activation of <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> , NFkappaB , and <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_1> Pathways", "LMP1 Promotes Tumor Growth and Survival through Activation of Akt , NFkappaB , and Stat3 Pathways"], "relation": []}
{"trigger": ["To explore which pathways were required for the enhanced growth and survival of <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> - induced lymphomas , splenocytes from wild-type and <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> transgenic mice were cultured in the presence of inhibitors for <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> , NFkappaB , <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_1> , <extra_id_0> mTOR <extra_id_2> Protein <extra_id_1> , or MAPK and assayed for growth and survival by the MTS assay .", "To explore which pathways were required for the enhanced growth and survival of LMP1 - induced lymphomas , splenocytes from wild-type and LMP1 transgenic mice were cultured in the presence of <extra_id_0> inhibitors <extra_id_2> Negative_regulation <extra_id_1> for Akt , NFkappaB , Stat3 , mTOR , or MAPK and assayed for growth and survival by the MTS assay ."], "relation": [["To explore which pathways were required for the enhanced growth and survival of LMP1 - induced lymphomas , splenocytes from wild-type and LMP1 transgenic mice were cultured in the presence of <extra_id_0> inhibitors <extra_id_2> Negative_regulation <extra_id_1> for Akt , NFkappaB , Stat3 , mTOR , or MAPK and assayed for growth and survival by the MTS assay .", "To explore which pathways were required for the enhanced growth and survival of LMP1 - induced lymphomas , splenocytes from wild-type and LMP1 transgenic mice were cultured in the presence of inhibitors for <extra_id_0> Akt <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> , NFkappaB , <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> , <extra_id_0> mTOR <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> , or MAPK and assayed for growth and survival by the MTS assay ."]]}
{"trigger": ["As previously shown , wild-type lymphocytes were not viable in culture and could not be tested with the inhibitors .", "As previously shown , wild-type lymphocytes were not viable in culture and could not be tested with the inhibitors ."], "relation": []}
{"trigger": ["However , the enhanced viability of <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> transgenic lymphocytes was effectively blocked by treatment with triciribine , BAY11-7085 , cucurbitacin I , and slightly with SB203580 , but not by treatment with rapamycin , U0126 , or AG490 ( Figure 7 ) .", "However , the enhanced viability of LMP1 transgenic lymphocytes was effectively blocked by treatment with triciribine , BAY11-7085 , cucurbitacin I , and slightly with SB203580 , but not by treatment with rapamycin , U0126 , or AG490 ( Figure 7 ) ."], "relation": []}
{"trigger": ["Triciribine inhibits the activation of <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> and at 20 muM has been shown to induce growth arrest in cancer cells with aberrant <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> activity [ 46 ] .", "Triciribine <extra_id_0> inhibits <extra_id_2> Negative_regulation <extra_id_1> the <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_1> of Akt and at 20 muM has been shown to induce growth arrest in cancer cells with aberrant Akt activity [ 46 ] ."], "relation": [["Triciribine <extra_id_0> inhibits <extra_id_2> Negative_regulation <extra_id_1> the activation of Akt and at 20 muM has been shown to induce growth arrest in cancer cells with aberrant Akt activity [ 46 ] .", "Triciribine inhibits the <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_2> Theme <extra_id_1> of Akt and at 20 muM has been shown to induce growth arrest in cancer cells with aberrant Akt activity [ 46 ] ."], ["Triciribine inhibits the <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_1> of Akt and at 20 muM has been shown to induce growth arrest in cancer cells with aberrant Akt activity [ 46 ] .", "Triciribine inhibits the activation of <extra_id_0> Akt <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> and at 20 muM has been shown to induce growth arrest in cancer cells with aberrant Akt activity [ 46 ] ."]]}
{"trigger": ["The effects of triciribine on cell growth of the transgenic lymphocytes and lymphomas were apparent as low as 1 muM , suggesting that activation of <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> is required for the survival and growth of <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> transgenic lymphocytes and lymphoma cells ( Figure 7 ) .", "The effects of triciribine on cell growth of the transgenic lymphocytes and lymphomas were apparent as low as 1 muM , suggesting that <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_1> of Akt is required for the survival and growth of LMP1 transgenic lymphocytes and lymphoma cells ( Figure 7 ) ."], "relation": [["The effects of triciribine on cell growth of the transgenic lymphocytes and lymphomas were apparent as low as 1 muM , suggesting that <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_1> of Akt is required for the survival and growth of LMP1 transgenic lymphocytes and lymphoma cells ( Figure 7 ) .", "The effects of triciribine on cell growth of the transgenic lymphocytes and lymphomas were apparent as low as 1 muM , suggesting that activation of <extra_id_0> Akt <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> is required for the survival and growth of LMP1 transgenic lymphocytes and lymphoma cells ( Figure 7 ) ."]]}
{"trigger": ["The effects of the inhibitors were assessed by identifying phosphorylated <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> , <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_1> , and total levels of <extra_id_0> IkappaBalpha <extra_id_2> Protein <extra_id_1> ( Figure 8 ) .", "The effects of the inhibitors were assessed by identifying <extra_id_0> phosphorylated <extra_id_2> Phosphorylation <extra_id_1> Akt , Stat3 , and total levels of IkappaBalpha ( Figure 8 ) ."], "relation": [["The effects of the inhibitors were assessed by identifying <extra_id_0> phosphorylated <extra_id_2> Phosphorylation <extra_id_1> Akt , Stat3 , and total levels of IkappaBalpha ( Figure 8 ) .", "The effects of the inhibitors were assessed by identifying phosphorylated <extra_id_0> Akt <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> , <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> , and total levels of IkappaBalpha ( Figure 8 ) ."]]}
{"trigger": ["Treatment with triciribine effectively blocked phosphorylation of <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> , and phosphorylated <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> was no longer detected past 5 muM .", "Treatment with triciribine effectively <extra_id_0> blocked <extra_id_2> Negative_regulation <extra_id_1> <extra_id_0> phosphorylation <extra_id_2> Phosphorylation <extra_id_1> of Akt , and <extra_id_0> phosphorylated <extra_id_2> Phosphorylation <extra_id_1> Akt was no longer <extra_id_0> detected <extra_id_2> Positive_regulation <extra_id_1> past 5 muM ."], "relation": [["Treatment with triciribine effectively <extra_id_0> blocked <extra_id_2> Negative_regulation <extra_id_1> phosphorylation of Akt , and phosphorylated Akt was no longer detected past 5 muM .", "Treatment with triciribine effectively blocked <extra_id_0> phosphorylation <extra_id_2> Phosphorylation <extra_id_2> Theme <extra_id_1> of Akt , and phosphorylated Akt was no longer detected past 5 muM ."], ["Treatment with triciribine effectively blocked <extra_id_0> phosphorylation <extra_id_2> Phosphorylation <extra_id_1> of Akt , and phosphorylated Akt was no longer detected past 5 muM .", "Treatment with triciribine effectively blocked phosphorylation of <extra_id_0> Akt <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> , and phosphorylated Akt was no longer detected past 5 muM ."], ["Treatment with triciribine effectively blocked phosphorylation of Akt , and <extra_id_0> phosphorylated <extra_id_2> Phosphorylation <extra_id_1> Akt was no longer detected past 5 muM .", "Treatment with triciribine effectively blocked phosphorylation of Akt , and phosphorylated <extra_id_0> Akt <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> was no longer detected past 5 muM ."], ["Treatment with triciribine effectively blocked phosphorylation of Akt , and phosphorylated Akt was no longer <extra_id_0> detected <extra_id_2> Positive_regulation <extra_id_1> past 5 muM .", "Treatment with triciribine effectively blocked phosphorylation of Akt , and <extra_id_0> phosphorylated <extra_id_2> Phosphorylation <extra_id_2> Theme <extra_id_1> Akt was no longer detected past 5 muM ."]]}
{"trigger": ["Phosphorylated <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_1> and <extra_id_0> IkappaBalpha <extra_id_2> Protein <extra_id_1> were still present at 25 muM .", "<extra_id_0> Phosphorylated <extra_id_2> Phosphorylation <extra_id_1> Stat3 and IkappaBalpha were still present at 25 muM ."], "relation": [["<extra_id_0> Phosphorylated <extra_id_2> Phosphorylation <extra_id_1> Stat3 and IkappaBalpha were still present at 25 muM .", "Phosphorylated <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> and <extra_id_0> IkappaBalpha <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> were still present at 25 muM ."]]}
{"trigger": ["These findings suggest that triciribine specifically targets <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> and that <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> activation is required for the enhanced viability of the transgenic lymphocytes and lymphoma cells .", "These findings suggest that triciribine specifically <extra_id_0> targets <extra_id_2> Regulation <extra_id_1> Akt and that Akt <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_1> is required for the enhanced viability of the transgenic lymphocytes and lymphoma cells ."], "relation": [["These findings suggest that triciribine specifically <extra_id_0> targets <extra_id_2> Regulation <extra_id_1> Akt and that Akt activation is required for the enhanced viability of the transgenic lymphocytes and lymphoma cells .", "These findings suggest that triciribine specifically targets <extra_id_0> Akt <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> and that Akt activation is required for the enhanced viability of the transgenic lymphocytes and lymphoma cells ."], ["These findings suggest that triciribine specifically targets Akt and that Akt <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_1> is required for the enhanced viability of the transgenic lymphocytes and lymphoma cells .", "These findings suggest that triciribine specifically targets Akt and that <extra_id_0> Akt <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> activation is required for the enhanced viability of the transgenic lymphocytes and lymphoma cells ."]]}
{"trigger": ["Inhibition of NFkappaB signaling rapidly induces cell death of EBV-transformed lymphocytes [ 17 , 18 ] .", "Inhibition of NFkappaB signaling rapidly induces cell death of EBV-transformed lymphocytes [ 17 , 18 ] ."], "relation": []}
{"trigger": ["BAY11-7085 , an inhibitor of NFkappaB signaling , also greatly decreased the viability of the <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> transgenic lymphocytes and lymphoma cells at doses as low as 1 muM , and at 5 muM the cells were completely nonviable ( Figure 7 ) .", "BAY11-7085 , an inhibitor of NFkappaB signaling , also greatly decreased the viability of the LMP1 transgenic lymphocytes and lymphoma cells at doses as low as 1 muM , and at 5 muM the cells were completely nonviable ( Figure 7 ) ."], "relation": []}
{"trigger": ["This is well within the reported IC50 of 10 muM .", "This is well within the reported IC50 of 10 muM ."], "relation": []}
{"trigger": ["Phosphorylated <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> , <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_1> , and total <extra_id_0> IkappaBalpha <extra_id_2> Protein <extra_id_1> were still present up to treatment with 15 muM and then were no longer detected ( Figure 8 ) .", "<extra_id_0> Phosphorylated <extra_id_2> Phosphorylation <extra_id_1> Akt , Stat3 , and total IkappaBalpha were still <extra_id_0> present <extra_id_2> Positive_regulation <extra_id_1> up to treatment with 15 muM and then were no longer <extra_id_0> detected <extra_id_2> Positive_regulation <extra_id_1> ( Figure 8 ) ."], "relation": [["<extra_id_0> Phosphorylated <extra_id_2> Phosphorylation <extra_id_1> Akt , Stat3 , and total IkappaBalpha were still present up to treatment with 15 muM and then were no longer detected ( Figure 8 ) .", "Phosphorylated <extra_id_0> Akt <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> , <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> , and total IkappaBalpha were still present up to treatment with 15 muM and then were no longer detected ( Figure 8 ) ."], ["Phosphorylated Akt , Stat3 , and total IkappaBalpha were still <extra_id_0> present <extra_id_2> Positive_regulation <extra_id_1> up to treatment with 15 muM and then were no longer detected ( Figure 8 ) .", "<extra_id_0> Phosphorylated <extra_id_2> Phosphorylation <extra_id_2> Theme <extra_id_1> Phosphorylated <extra_id_2> Phosphorylation <extra_id_2> Theme <extra_id_1> Akt , Stat3 , and total <extra_id_0> IkappaBalpha <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> were still present up to treatment with 15 muM and then were no longer detected ( Figure 8 ) ."], ["Phosphorylated Akt , Stat3 , and total IkappaBalpha were still present up to treatment with 15 muM and then were no longer <extra_id_0> detected <extra_id_2> Positive_regulation <extra_id_1> ( Figure 8 ) .", "<extra_id_0> Phosphorylated <extra_id_2> Phosphorylation <extra_id_2> Theme <extra_id_1> Phosphorylated <extra_id_2> Phosphorylation <extra_id_2> Theme <extra_id_1> Akt , Stat3 , and total <extra_id_0> IkappaBalpha <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> were still present up to treatment with 15 muM and then were no longer detected ( Figure 8 ) ."]]}
{"trigger": ["This finding suggests that inhibition of NFkappaB can induce cell death in <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> transgenic lymphocytes and lymphoma cells without significant effects on activation of <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> or <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_1> .", "This finding suggests that inhibition of NFkappaB can induce cell death in LMP1 transgenic lymphocytes and lymphoma cells without significant <extra_id_0> effects <extra_id_2> Regulation <extra_id_1> on <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_1> of Akt or Stat3 ."], "relation": [["This finding suggests that inhibition of NFkappaB can induce cell death in LMP1 transgenic lymphocytes and lymphoma cells without significant <extra_id_0> effects <extra_id_2> Regulation <extra_id_1> on activation of Akt or Stat3 .", "This finding suggests that inhibition of NFkappaB can induce cell death in LMP1 transgenic lymphocytes and lymphoma cells without significant effects on <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_2> Theme <extra_id_1> activation <extra_id_2> Positive_regulation <extra_id_2> Theme <extra_id_1> of Akt or Stat3 ."], ["This finding suggests that inhibition of NFkappaB can induce cell death in LMP1 transgenic lymphocytes and lymphoma cells without significant effects on <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_1> of Akt or Stat3 .", "This finding suggests that inhibition of NFkappaB can induce cell death in LMP1 transgenic lymphocytes and lymphoma cells without significant effects on activation of <extra_id_0> Akt <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> or <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> ."]]}
{"trigger": ["Cucurbitacin I inhibits activation of <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_1> by suppressing the activation of its kinase <extra_id_0> JAK2 <extra_id_2> Protein <extra_id_1> .", "Cucurbitacin I <extra_id_0> inhibits <extra_id_2> Negative_regulation <extra_id_1> <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_1> of Stat3 by suppressing the activation of its kinase JAK2 ."], "relation": [["Cucurbitacin I <extra_id_0> inhibits <extra_id_2> Negative_regulation <extra_id_1> activation of Stat3 by suppressing the activation of its kinase JAK2 .", "Cucurbitacin I inhibits <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_2> Theme <extra_id_1> of Stat3 by suppressing the activation of its kinase JAK2 ."], ["Cucurbitacin I inhibits <extra_id_0> activation <extra_id_2> Positive_regulation <extra_id_1> of Stat3 by suppressing the activation of its kinase JAK2 .", "Cucurbitacin I inhibits activation of <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> by suppressing the activation of its kinase JAK2 ."]]}
{"trigger": ["It has been shown to selectively inhibit the growth of tumors with constitutively activated <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_1> [ 47 ] .", "It has been shown to selectively inhibit the growth of tumors with constitutively <extra_id_0> activated <extra_id_2> Positive_regulation <extra_id_1> Stat3 [ 47 ] ."], "relation": [["It has been shown to selectively inhibit the growth of tumors with constitutively <extra_id_0> activated <extra_id_2> Positive_regulation <extra_id_1> Stat3 [ 47 ] .", "It has been shown to selectively inhibit the growth of tumors with constitutively activated <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> [ 47 ] ."]]}
{"trigger": ["Similarly , <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> transgenic lymphocytes and lymphoma cells were susceptible to cucurbitacin I treatment starting at 0.1 muM , a dose that corresponds closely to the reported IC50 of 500 nM ( Figure 7 ) [ 47 ] .", "Similarly , LMP1 transgenic lymphocytes and lymphoma cells were susceptible to cucurbitacin I treatment starting at 0.1 muM , a dose that corresponds closely to the reported IC50 of 500 nM ( Figure 7 ) [ 47 ] ."], "relation": []}
{"trigger": ["Phosphorylated <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> , <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_1> , and total <extra_id_0> IkappaBalpha <extra_id_2> Protein <extra_id_1> were not detectable past 1 muM and at higher doses all protein levels were greatly decreased , indicative of the total loss of viability ( Figure 8 ) .", "<extra_id_0> Phosphorylated <extra_id_2> Phosphorylation <extra_id_1> Akt , Stat3 , and total IkappaBalpha were not <extra_id_0> detectable <extra_id_2> Positive_regulation <extra_id_1> past 1 muM and at higher doses all protein levels were greatly <extra_id_0> decreased <extra_id_2> Negative_regulation <extra_id_1> , indicative of the total loss of viability ( Figure 8 ) ."], "relation": [["<extra_id_0> Phosphorylated <extra_id_2> Phosphorylation <extra_id_1> Akt , Stat3 , and total IkappaBalpha were not detectable past 1 muM and at higher doses all protein levels were greatly decreased , indicative of the total loss of viability ( Figure 8 ) .", "Phosphorylated <extra_id_0> Akt <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> , <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> , and total IkappaBalpha were not detectable past 1 muM and at higher doses all protein levels were greatly decreased , indicative of the total loss of viability ( Figure 8 ) ."], ["Phosphorylated Akt , Stat3 , and total IkappaBalpha were not <extra_id_0> detectable <extra_id_2> Positive_regulation <extra_id_1> past 1 muM and at higher doses all protein levels were greatly decreased , indicative of the total loss of viability ( Figure 8 ) .", "Phosphorylated <extra_id_0> Akt <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> , <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> , and total <extra_id_0> IkappaBalpha <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> were not detectable past 1 muM and at higher doses all protein levels were greatly decreased , indicative of the total loss of viability ( Figure 8 ) ."], ["Phosphorylated Akt , Stat3 , and total IkappaBalpha were not detectable past 1 muM and at higher doses all protein levels were greatly <extra_id_0> decreased <extra_id_2> Negative_regulation <extra_id_1> , indicative of the total loss of viability ( Figure 8 ) .", "Phosphorylated <extra_id_0> Akt <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> , <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> , and total <extra_id_0> IkappaBalpha <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> were not detectable past 1 muM and at higher doses all protein levels were greatly decreased , indicative of the total loss of viability ( Figure 8 ) ."]]}
{"trigger": ["A second reported inhibitor of <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_1> , AG490 , had no effect on growth ( Figure 7 ) , but activation of <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> , <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_1> , or levels of <extra_id_0> IkappaBalpha <extra_id_2> Protein <extra_id_1> were also not affected ( Figure 8 ) .", "A second reported <extra_id_0> inhibitor <extra_id_2> Negative_regulation <extra_id_1> of Stat3 , AG490 , had no effect on growth ( Figure 7 ) , but activation of Akt , Stat3 , or levels of IkappaBalpha were also not <extra_id_0> affected <extra_id_2> Regulation <extra_id_1> ( Figure 8 ) ."], "relation": [["A second reported <extra_id_0> inhibitor <extra_id_2> Negative_regulation <extra_id_1> of Stat3 , AG490 , had no effect on growth ( Figure 7 ) , but activation of Akt , Stat3 , or levels of IkappaBalpha were also not affected ( Figure 8 ) .", "A second reported inhibitor of <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> , AG490 , had no effect on growth ( Figure 7 ) , but activation of Akt , Stat3 , or levels of IkappaBalpha were also not affected ( Figure 8 ) ."], ["A second reported inhibitor of Stat3 , AG490 , had no effect on growth ( Figure 7 ) , but activation of Akt , Stat3 , or levels of IkappaBalpha were also not <extra_id_0> affected <extra_id_2> Regulation <extra_id_1> ( Figure 8 ) .", "A second reported inhibitor of Stat3 , AG490 , had no effect on growth ( Figure 7 ) , but activation of Akt , Stat3 , or levels of <extra_id_0> IkappaBalpha <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> were also not affected ( Figure 8 ) ."]]}
{"trigger": ["These findings suggest that inhibition of <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_1> can induce cell death in <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> transgenic lymphocytes and lymphoma cells , but <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_1> inhibition also has considerable crossover effects on <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> and NFkappaB signaling .", "These findings suggest that <extra_id_0> inhibition <extra_id_2> Negative_regulation <extra_id_1> of Stat3 can induce cell death in LMP1 transgenic lymphocytes and lymphoma cells , but Stat3 <extra_id_0> inhibition <extra_id_2> Negative_regulation <extra_id_1> also has considerable crossover effects on Akt and NFkappaB signaling ."], "relation": [["These findings suggest that <extra_id_0> inhibition <extra_id_2> Negative_regulation <extra_id_1> of Stat3 can induce cell death in LMP1 transgenic lymphocytes and lymphoma cells , but Stat3 inhibition also has considerable crossover effects on Akt and NFkappaB signaling .", "These findings suggest that inhibition of <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> can induce cell death in LMP1 transgenic lymphocytes and lymphoma cells , but Stat3 inhibition also has considerable crossover effects on Akt and NFkappaB signaling ."], ["These findings suggest that inhibition of Stat3 can induce cell death in LMP1 transgenic lymphocytes and lymphoma cells , but Stat3 <extra_id_0> inhibition <extra_id_2> Negative_regulation <extra_id_1> also has considerable crossover effects on Akt and NFkappaB signaling .", "These findings suggest that inhibition of Stat3 can induce cell death in LMP1 transgenic lymphocytes and lymphoma cells , but <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> inhibition also has considerable crossover effects on Akt and NFkappaB signaling ."]]}
{"trigger": ["<extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> has also been shown to activate JNK and p38 MAPK pathways [ 13 , 48 ] , and <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> transgenic lymphocytes were mildly susceptible to growth inhibition by SB202190 , an inhibitor of p38 MAPK , but not U0126 , an inhibitor of <extra_id_0> MEK1 <extra_id_2> Protein <extra_id_1> / <extra_id_0> 2 <extra_id_2> Protein <extra_id_1> activity .", "LMP1 has also been shown to activate JNK and p38 MAPK pathways [ 13 , 48 ] , and LMP1 transgenic lymphocytes were mildly susceptible to growth inhibition by SB202190 , an inhibitor of p38 MAPK , but not U0126 , an <extra_id_0> inhibitor <extra_id_2> Negative_regulation <extra_id_1> of MEK1 / 2 activity ."], "relation": [["LMP1 has also been shown to activate JNK and p38 MAPK pathways [ 13 , 48 ] , and LMP1 transgenic lymphocytes were mildly susceptible to growth inhibition by SB202190 , an inhibitor of p38 MAPK , but not U0126 , an <extra_id_0> inhibitor <extra_id_2> Negative_regulation <extra_id_1> of MEK1 / 2 activity .", "LMP1 has also been shown to activate JNK and p38 MAPK pathways [ 13 , 48 ] , and LMP1 transgenic lymphocytes were mildly susceptible to growth inhibition by SB202190 , an inhibitor of p38 MAPK , but not U0126 , an inhibitor of <extra_id_0> MEK1 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> / <extra_id_0> 2 <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> activity ."]]}
{"trigger": ["However , effects of SB202190 were only apparent at high doses ( > 10 muM ) , much higher than the reported IC50 of 0.35 muM , suggesting that p38 MAPK does not significantly contribute to the enhanced viability in <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> transgenic lymphocytes or lymphoma cells ( Figure 7 ) .", "However , effects of SB202190 were only apparent at high doses ( > 10 muM ) , much higher than the reported IC50 of 0.35 muM , suggesting that p38 MAPK does not significantly contribute to the enhanced viability in LMP1 transgenic lymphocytes or lymphoma cells ( Figure 7 ) ."], "relation": []}
{"trigger": ["Interestingly , both wild-type and <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> transgenic lymphomas were similarly susceptible to triciribine , BAY11-7085 , and cucurbitacin I treatments , but not SB202190 , AG490 , or U0126 treatment , suggesting that activation of <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> , NFkappaB , and <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_1> but not MAPK pathways are characteristics associated with malignant transformation ( Figure 7 ) .", "Interestingly , both wild-type and LMP1 transgenic lymphomas were similarly susceptible to triciribine , BAY11-7085 , and cucurbitacin I treatments , but not SB202190 , AG490 , or U0126 treatment , suggesting that activation of Akt , NFkappaB , and Stat3 but not MAPK pathways are characteristics associated with malignant transformation ( Figure 7 ) ."], "relation": []}
{"trigger": ["rapamycin , an inhibitor of <extra_id_0> mTOR <extra_id_2> Protein <extra_id_1> , did not affect the viability of the transgenic lymphocytes or lymphoma cells , confirming that <extra_id_0> mTOR <extra_id_2> Protein <extra_id_1> is not targeted by <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> activation in <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> transgenic lymphocytes or malignant lymphoma cells ( Figure 7 ) .", "rapamycin , an <extra_id_0> inhibitor <extra_id_2> Negative_regulation <extra_id_1> of mTOR , did not affect the viability of the transgenic lymphocytes or lymphoma cells , confirming that mTOR is not <extra_id_0> targeted <extra_id_2> Regulation <extra_id_1> by Akt activation in LMP1 transgenic lymphocytes or malignant lymphoma cells ( Figure 7 ) ."], "relation": [["rapamycin , an <extra_id_0> inhibitor <extra_id_2> Negative_regulation <extra_id_1> of mTOR , did not affect the viability of the transgenic lymphocytes or lymphoma cells , confirming that mTOR is not targeted by Akt activation in LMP1 transgenic lymphocytes or malignant lymphoma cells ( Figure 7 ) .", "rapamycin , an inhibitor of <extra_id_0> mTOR <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> , did not affect the viability of the transgenic lymphocytes or lymphoma cells , confirming that mTOR is not targeted by Akt activation in LMP1 transgenic lymphocytes or malignant lymphoma cells ( Figure 7 ) ."], ["rapamycin , an inhibitor of mTOR , did not affect the viability of the transgenic lymphocytes or lymphoma cells , confirming that mTOR is not <extra_id_0> targeted <extra_id_2> Regulation <extra_id_1> by Akt activation in LMP1 transgenic lymphocytes or malignant lymphoma cells ( Figure 7 ) .", "rapamycin , an inhibitor of mTOR , did not affect the viability of the transgenic lymphocytes or lymphoma cells , confirming that <extra_id_0> mTOR <extra_id_2> Protein <extra_id_2> Theme <extra_id_1> is not targeted by Akt activation in LMP1 transgenic lymphocytes or malignant lymphoma cells ( Figure 7 ) ."]]}
